CXCL11 and colitis: Interestingly, our data clearly showed that administration of IL-17A attenuated the ability of CECs from TNBS-induced colitis mice to induce colitis when transferred into recipients and decreased the expression of CXCL11, IL-12P35, and IFN-γ (Fig. 7B).